UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of September, 2024
Commission File Number: 001-36619
Affimed N.V.
Gottlieb-Daimler-Straße 2,
68165 Mannheim
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
AFFIMED N.V.
On September 11, 2024, Affimed N.V. announced an extraordinary general meeting of shareholders to be held on October 10, 2024 and made available to its shareholders certain other materials in connection with such meeting.
Such materials are attached as exhibits to this Form 6-K and are incorporated by reference herein.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
AFFIMED N.V. | ||||||
Date: September 11, 2024 | By: | /s/ Andreas Harstrick | ||||
Name: | Andreas Harstrick | |||||
Title: | Chief Medical Officer | |||||
By: | /s/ Denise Mueller | |||||
Name: | Denise Mueller | |||||
Title: | Chief Business Officer |
2
EXHIBIT INDEX
Exhibit | Description of Exhibit | |
99.1 | Notice convening the extraordinary general meeting of shareholders | |
99.2 | Agenda including explanation | |
99.3 | Powers of attorney |
3